DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit …

This post was originally published on this site

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of MultiPlan Corporation (NYSE; MPLN, MPLN.WS, CCXX, CCXX.WS, CCXX.U) between July 12, 2020 and November 10, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=multiplan-corporation&id=2634 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email  info@zhanginvestorlaw.com  for information on the class action.

ADVERTISEMENT

如果您想加入这个集体诉讼案,请在这里提交您的信息。 http://zhanginvestorlaw.com/join-action-form/?slug=multiplan-corporation&id=2634

If you wish to serve as lead plaintiff, you must move the Court before the April 26, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- MultiPlan was losing tens of millions of dollars in sales and revenues to Naviguard, a competitor created by one of MultiPlan’s largest customers, UnitedHealthcare, which threatened up to 35% of the Company’s sales and 80% of its levered cash flows by 2022; sales and revenue declines in the quarters leading up to the Merger were not due to “idiosyncratic” customer behaviors as represented, but rather due to a fundamental deterioration in demand for MultiPlan’s services and increased competition, as payors developed competing services and sought alternatives to eliminating excessive healthcare costs; MultiPlan was facing significant pricing pressures for its services and had been forced to materially reduce its take rate in the lead up to the Merger by insurers, who had expressed dissatisfaction with the price and quality of MultiPlan’s services and balanced billing practices, causing the Company’s to cut its take rate by up to half in some cases; as a result of the foregoing, Churchill III investors had grossly overpaid for the acquisition of MultiPlan in the Merger, and MultiPlan’s business was worth far less than represented to investors. According to the suit, these true details were disclosed by a market research firm.

ADVERTISEMENT

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756